Morena-Carrere et al. identified severe coronary artery calcifications (CAC) in CKD patients as a major predictor of adverse cardiovascular events, with elevated sclerostin and other bone-related markers exacerbating cardiovascular mortality [23]. The gene discussed is SOST; the disease is chronic kidney disease.